Cann10 is owned by Shizim Group, an integrated Life Science and Health Tech holding company, dedicated to
enabling medical cannabis to reach its full potential worldwide.
Shizim Group is Israel’s leading life science and bio medical device organization. Shizim is at the forefront of entrepreneurship, biomed, clinical research, regulatory affairs, R&D support, as well as marketing and business development services. It offers extensive connections and investors worldwide. Shizim has operations in Europe, China. Australia, US and Canada.
Yossi Bornstein is the founder and Chairman of Shizim. He is also Chairman of Cann10. Shizim currently runs two accelerators: Cann10 for companies in the medical cannabis field and Shizim XL related to medical devices.